Key stats
About ISHARES IV PLC NASDAQ US BIOTECH UCITS USD ACC
Expense ratio
0.35%
Home page
Inception date
Oct 19, 2017
ISIN
IE00BYXG2H39
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.89%
Health Technology97.38%
Commercial Services1.43%
Technology Services0.57%
Health Services0.46%
Process Industries0.04%
Bonds, Cash & Other0.11%
Cash0.11%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history